Demand for semaglutide and tirzepatide that far outran supply, driven by adoption for weight management well beyond the diabetes population these products were first built around
While Semaglutide offers a promising solution for many, its not suitable for: Individuals with a history of pancreatitis, MTC, gastrointestinal diseases, gastroparesis, gallbladder disease, or MEN2 Pregnant or breastfeeding women Those allergic to Semaglutide or its components Interactions with Other Medications Before starting Semaglutide, discussing your current medication regimen with your healthcare provider is crucial
Patients who continue exercising after reaching their target weight maintain their results more successfully than those who stop
Notably, recent evidence suggests that the adverse impact of obesity on ART outcomes is substantially mitigated in donor oocyte cycles, supporting a dominant role of oocyte quality rather than endometrial receptivity in certain contexts [9]
